PharmGKB summary: ibuprofen pathways.

@article{Mazaleuskaya2015PharmGKBSI,
  title={PharmGKB summary: ibuprofen pathways.},
  author={Liudmila L. Mazaleuskaya and Katherine N. Theken and Li K. Gong and Caroline F. Thorn and Garret A. FitzGerald and Russ B. Altman and Teri E. Klein},
  journal={Pharmacogenetics and genomics},
  year={2015},
  volume={25 2},
  pages={
          96-106
        }
}
Ibuprofen is a traditional nonsteroidal anti-inflammatory drug (NSAID) widely used for its analgesic, anti-inflammatory, and antipyretic properties [1,2]. At low over-the-counter doses (800–1200 mg/day), ibuprofen is indicated to relieve minor pain and inflammation, including headache, muscular aches, toothache, fever, backache, and dysmenorrhea. At prescription doses (1800–2400 mg/day), it is used for the long-term treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

A novel technique for intraduodenal administration of drug suspensions/solutions with concurrent pH monitoring applied to ibuprofen formulations.

  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

Update on the pathophysiology and treatment of rhinogenic headache: focus on the ibuprofen/pseudoephedrine combination

  • Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale
  • 2019

Immunomodulatory Cell Therapy to Target Cystic Fibrosis Inflammation.

  • American journal of respiratory cell and molecular biology
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 107 REFERENCES

Similar Papers

Loading similar papers…